Material Agreement – Form 8-K

On October 30, 2023, Acadia Healthcare Company, Inc. ("Acadia" or "the Company") and its subsidiary Youth and Family Centered Services of New Mexico ("Desert Hills") entered into settlement agreements (collectively, the "Settlement Agreements") in connection with Acadia and Desert Hills' previously disclosed civil litigation in New Mexico State District Court (the "District Court"), Inman v. Garcia, et al, Case No. D-117-CV-2019-00136,Rael v. Garcia, et al, Case No. D-117-CV-2019-00135andEndicott-Quinones v. Garcia, et al, Case No. D-117-CV-2019-00137(collectively, the "Cases").

The Settlement Agreements, which resulted from the settlement discussions previously disclosed by the Company on its Current Report on Form 8-Kfiled on October 11, 2023, fully resolve each of the Cases and include no admission or finding of liability by Acadia or Desert Hills. Under the terms of the Settlement Agreements, which are subject to approval by the District Court, the Company will pay an aggregate amount of $400 million in exchange for the release and discharge of all claims arising from, relating to, concerning or with respect to all harm, injuries or damages asserted or that may be asserted in the future.

The foregoing description of the Settlement Agreements is qualified in its entirety by reference to the full text of the Settlement Agreements, copies of which are filed herewith as Exhibits 10.1, 10.2 and 10.3 and incorporated herein by reference.

The Company currently intends to pay the funds associated with the Settlement Agreements from a combination of insurance, cash on hand and existing credit lines; the funds are due 30 days from the date of the last District Court's approval of the relevant settlement agreement. The Company will record the aggregate settlement amount, less associated tax benefits, as an expense for the quarter ending September 30, 2023.

Because the settlement funds will be excluded from adjusted EBITDA, the settlement has no impact on the Company's previously announced financial guidance. The Company also affirmed that it maintains a strong financial position with sufficient capital to make strategic investments in its business. As of June 30, 2023, the Company had $112.2 million in cash and cash equivalents and $505 million available under its $600 million revolving credit facility with a net leverage ratio of approximately 2.0x.

Cautionary Statements Regarding Forward-Looking Statements

The foregoing discussion of the Cases and the Settlement Agreements contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause the Company's future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as "should," "expect," "anticipate," "estimate," "target," "may," "project," "guidance," "intend," "plan," "believe" and other words and terms of similar meaning and expression. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, the Company undertakes no obligation to publicly update forward-looking statements. Investors should read the important risk factors described in the Company's most recent Annual Report on Form 10-K,Quarterly Reports on Form 10-Qand Current Reports on Form 8-Kfiled with the U.S. Securities and Exchange Commission.

Attachments

• Original Link
• Original Document
• Permalink

Disclaimer

Acadia Healthcare Company Inc. published this content on 30 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 October 2023 20:51:59 UTC.